Most just lately, it's been discovered that conolidine and the above derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Compared with most opioid receptors, this receptor functions like a scavenger https://davidl616wdg9.qodsblog.com/profile